3 ms·
This is only true if a one-off sale of the cure is significantly more profitable than a reliable income stream from products that help manage the disease withou
by TheOtherHobbes 10y ago
This is only true if a one-off sale of the cure is significantly more profitable than a reliable income stream from products that help manage the disease without curing it.
For that to be true the cure would have to be more expensive than management by at least an order of magnitude - assuming monthly refills for management and an annual reporting cycle - but still not so expensive that it became unaffordable.
- sillysaurus3 10y agoCan someone provide links to examples of companies withholding cures in exchange for profit? If not, the idea of this is nothing but conspiratorial. If it's true, though, it's worth knowing.
- TheOtherHobbes 10y agoI wasn't being conspiratorial, so much as adding some detail to a market-based model. As in the other post below, I don't believe magic bullet cures are possible for most diseases. Following that economic logic further, it's much cheaper and easier to produce a not-very-effective but marketable palliative than it is to aim for a Nobel-winning medical moonshot. I don't know of any suppressed super-cures, but evidence confirming the limited effectiveness of (e.g.) SSRIs is easy to find and hard to argue with. Similarly questionable outcomes have been noted in other fields. E.g. novel anticoagulants: https://en.wikipedia.org/wiki/Dabigatran https://en.wikipedia.org/wiki/Dabigatran
- Xoros 10y agoMy original statement was about how much money goes in treatment research vs in cure research. Not about some conspiracy :-)